These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
167 related items for PubMed ID: 29358027
1. Design, synthesis and biological evaluation of new carbazole derivatives as anti-cancer and anti-migratory agents. Vlaar CP, Castillo-Pichardo L, Medina JI, Marrero-Serra CM, Vélez E, Ramos Z, Hernández E. Bioorg Med Chem; 2018 Feb 15; 26(4):884-890. PubMed ID: 29358027 [Abstract] [Full Text] [Related]
2. Synthesis, Anti-Cancer and Anti-Migratory Evaluation of 3,6-Dibromocarbazole and 5-Bromoindole Derivatives. Butler-Fernández KM, Ramos Z, Francis-Malavé AM, Bloom J, Dharmawardhane S, Hernández E. Molecules; 2019 Jul 24; 24(15):. PubMed ID: 31344865 [Abstract] [Full Text] [Related]
3. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM, AboulWafa OM, Baghdadi HH, Abd El Razik HA, Sedra SMY, Shamaa MM. Bioorg Chem; 2021 Oct 24; 115():105208. PubMed ID: 34365057 [Abstract] [Full Text] [Related]
4. Characterization of EHop-016, novel small molecule inhibitor of Rac GTPase. Montalvo-Ortiz BL, Castillo-Pichardo L, Hernández E, Humphries-Bickley T, De la Mota-Peynado A, Cubano LA, Vlaar CP, Dharmawardhane S. J Biol Chem; 2012 Apr 13; 287(16):13228-38. PubMed ID: 22383527 [Abstract] [Full Text] [Related]
6. Incarvine C and its analogues inhibit the formation of cell cytoskeleton by targeting Rac1. Zhao P, Zhang J, Song W, Qi D, Huang Y, Su Y, Wu R, Zhang L, Zhang S. Bioorg Chem; 2024 Aug 13; 149():107512. PubMed ID: 38833990 [Abstract] [Full Text] [Related]
7. Synthesis and biological evaluation of novel pyrano[3,2-c]carbazole derivatives as anti-tumor agents inducing apoptosis via tubulin polymerization inhibition. Padmaja P, Koteswara Rao G, Indrasena A, Subba Reddy BV, Patel N, Shaik AB, Reddy N, Dubey PK, Bhadra MP. Org Biomol Chem; 2015 Feb 07; 13(5):1404-14. PubMed ID: 25467166 [Abstract] [Full Text] [Related]
9. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents. Dimov S, Mavrova AT, Yancheva D, Nikolova B, Tsoneva I. Anticancer Agents Med Chem; 2021 Feb 07; 21(11):1441-1450. PubMed ID: 32698751 [Abstract] [Full Text] [Related]
10. Selective and effective anticancer agents: Synthesis, biological evaluation and structure-activity relationships of novel carbazole derivatives. Huang W, Gao Z, Zhang Z, Fang W, Wang Z, Wan Z, Shi L, Wang K, Ke S. Bioorg Chem; 2021 Aug 07; 113():104991. PubMed ID: 34051416 [Abstract] [Full Text] [Related]
11. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR, Penthala NR, Ketkar A, Eoff RL, Trujullo-Alonso V, Guzman ML, Crooks PA. Anticancer Agents Med Chem; 2018 Aug 07; 18(4):556-564. PubMed ID: 28403783 [Abstract] [Full Text] [Related]
12. Preclinical development of novel Rac1-GEF signaling inhibitors using a rational design approach in highly aggressive breast cancer cell lines. Cardama GA, Comin MJ, Hornos L, Gonzalez N, Defelipe L, Turjanski AG, Alonso DF, Gomez DE, Menna PL. Anticancer Agents Med Chem; 2014 Aug 07; 14(6):840-51. PubMed ID: 24066799 [Abstract] [Full Text] [Related]
13. Synthesis and biological evaluation of pyranocarbazole derivatives as Anti-tumor agents. Liu K, Zang Y, Shen C, Li C, Ma J, Yang J, Sun X, Chen X, Wang N, Zhang D. Bioorg Med Chem Lett; 2021 Feb 01; 33():127739. PubMed ID: 33316408 [Abstract] [Full Text] [Related]
15. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme. El-Helby AA, Sakr H, Ayyad RRA, El-Adl K, Ali MM, Khedr F. Anticancer Agents Med Chem; 2018 Feb 01; 18(8):1184-1196. PubMed ID: 29651967 [Abstract] [Full Text] [Related]
16. Design, synthesis and biological evaluation of novel 2,4-bismorpholinothieno[3,2-d]pyrimidine and 2-morpholinothieno[3,2-d]pyrimidinone derivatives as potent antitumor agents. Ye T, Han Y, Wang R, Yan P, Chen S, Hou Y, Zhao Y. Bioorg Chem; 2020 Jun 01; 99():103796. PubMed ID: 32283346 [Abstract] [Full Text] [Related]